Curevo Funding: $192M Raised, Series B (2025)

Curevo funding overview

Curevo is a Biotech company based in Seattle. Curevo has raised $192M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2025. The round record for Curevo runs through 2025; nothing later has been disclosed. Investors on record include Medicxi, OrbiMed, HBM Healthcare Investments, Sanofi Ventures, RA Capital Management, Janus Henderson Investors and 2 others. 8 distinct backers are named across the disclosed rounds.

Curevo at a glance

Total raised: $192M
Latest round: Series B
Latest round date: March 2025
Industry: Biotech
Headquarters: Seattle
Notable investors: Medicxi, OrbiMed, HBM Healthcare Investments, Sanofi Ventures, RA Capital Management, Janus Henderson Investors, Adjuvant Capital, GC Biopharma

Frequently asked about Curevo funding

How much has Curevo raised?: Curevo has raised $192M in total disclosed funding across the rounds on record.
Who has invested in Curevo?: Medicxi, OrbiMed, HBM Healthcare Investments, Sanofi Ventures, RA Capital Management, Janus Henderson Investors are named among the investors backing Curevo.
What was the latest Curevo funding round?: The most recent disclosed round is a Series B, announced in March 2025.
Where is Curevo based?: Curevo is based in Seattle.
What sector does Curevo operate in?: Curevo is tracked under Biotech from Seattle, with $192M in disclosed funding.
When did Curevo last raise?: The last disclosed Curevo round closed in March 2025 at Series B.

Curevo totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Seattle below to benchmark round size and investor mix.

Curevo Funding: $192M Raised, Series B (2025)

Curevo funding overview

Curevo at a glance

Frequently asked about Curevo funding

Curevo founders (1)

Companies related to Curevo (40)

Browse related funding lists (10)